Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
about
Regulation of inflammation in cancer by eicosanoidsCyclooxygenase-2 promotes tumor growth and suppresses tumor immunityE-type prostanoid receptor 4 (EP4) in disease and therapyEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesCOX-2 and PGE2-dependent immunomodulation in breast cancerImmunosuppression associated with chronic inflammation in the tumor microenvironmentCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardCyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomasNovel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemopreventionCyclooxygenase-2 and the inflammogenesis of breast cancer.Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.Characterization of scavengers of gamma-ketoaldehydes that do not inhibit prostaglandin biosynthesis.Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways.Abnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: a meta-analysis.Chemical 'Jekyll and Hyde's: small-molecule inhibitors of developmental signaling pathwaysCase-control study of aspirin use and risk of pancreatic cancer.Eicosanoids and cancerSpecialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort.Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte functionNuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice.Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposingA review of the application of inflammatory biomarkers in epidemiologic cancer research.Platelets and cancer: a casual or causal relationship: revisited.Anti-cancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoproteinEffect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer.Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.Animal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacologyCyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.Anticancer effects of 4-vinyl-2,6-dimethoxyphenol (canolol) against SGC-7901 human gastric carcinoma cellsPlatelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.Global gene expression profiling of a population exposed to a range of benzene levels.Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasiaA systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancerTrianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways.Autocrine prostaglandin E₂ signaling promotes promonocytic leukemia cell survival via COX-2 expression and MAPK pathwayThe role of COX-2 in intestinal inflammation and colorectal cancerIntegrin α3β1 as a breast cancer target
P2860
Q24564308-A3235474-70CC-47B0-B74C-A53D65528CE5Q26778534-333EE29B-611A-4419-86A9-D0825521E056Q26851156-35866157-28E9-4428-8E3B-2E15BC4A3E9AQ26862642-0C9C6520-B6C2-457B-A009-654823E57715Q27003937-CFFEEAE6-817D-4862-BA70-91D50C7CAEA8Q28083450-AEF5D5D6-2FA4-4A6C-BA2F-75C602BDFC47Q28274081-6C61D971-65E6-424C-9856-D471F919E14CQ28293433-33080FC3-15FE-4B28-9636-31264CAE7389Q28829463-E4862FC8-E84C-493B-B999-9DF15D319EEEQ30367680-AC574465-C1B2-4E01-946F-FD13B17609B4Q33575734-0AB65EB0-D88A-4D47-9518-377ADF5399F8Q33664316-630FCF91-2AD0-48A6-96B6-A95F9013AAE4Q33701495-1B5EEFCA-E16F-40C3-B700-6CE81CAE77A5Q33749203-6E2A76CC-3077-4A15-A5E3-F64F520A8418Q33852902-AFF38261-0F51-4890-AB5C-DCFEFDEA0487Q33877283-732D7B5D-243F-43F9-94E9-5D6AE74D8D93Q33881059-74431418-D6F0-4C04-9C43-8B81A2E8AA38Q33966203-CF370829-B6BD-426A-AB57-E888B9FE1F6AQ34003218-E76438E5-2E16-43EA-B695-77327B7CC15DQ34009960-8A4CE302-5F20-4ADC-8619-9D8061BB884DQ34010008-71B75DB9-59E3-4705-AFCD-D71A1BEF2B3EQ34067846-AE4A61C3-7E52-4E5F-876F-58910A2A0890Q34101536-7870C331-A6D1-4255-B4B9-7F944C524C02Q34135803-B26273C6-C9F8-4ECF-9AA8-3A1FAA8CBCA8Q34294719-091F2B62-DFEC-4CF2-BE26-99B82982391BQ34361606-67836E4B-893A-4D71-B19C-40DE21CD1611Q34458235-5FFE558D-06D4-4440-8B76-190FC0E51ECFQ34460302-C468C23B-DC0D-47CE-B459-9447DCF2E01FQ34536921-741F0B54-F8FE-4102-9EBF-823F9A21681EQ34541077-B2B8AC20-46E9-431B-9AF1-6B1912CC08F9Q34726849-42E2EAAC-E821-4F39-ADAC-723B216FDEBCQ34769188-3FDB71A9-1A58-4DCD-A437-204895892E21Q34782186-E4B176FD-BD16-4C26-85BE-389DCEAC1C94Q34980955-25893C4F-1039-487A-9995-895101952D4BQ35069458-92DD5E87-9C66-4BD7-98FF-65B00CE448F7Q35108403-C862FD4C-178D-4B56-A44F-98A53C3E5E4AQ35138880-0247815C-C45D-420A-B1FB-8D7628076454Q35156482-054131CF-1918-4A44-A136-9A6814F161F1Q35234704-A96FC478-9D8F-49D7-A019-D7A6C7E396F1Q35539262-88F4F1B9-1AEC-42B7-A8CE-DA9E99859184
P2860
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclooxygenase-2 (cox-2) block ...... n, breast, prostate, and lung.
@en
Cyclooxygenase-2 (cox-2) block ...... n, breast, prostate, and lung.
@nl
type
label
Cyclooxygenase-2 (cox-2) block ...... n, breast, prostate, and lung.
@en
Cyclooxygenase-2 (cox-2) block ...... n, breast, prostate, and lung.
@nl
prefLabel
Cyclooxygenase-2 (cox-2) block ...... n, breast, prostate, and lung.
@en
Cyclooxygenase-2 (cox-2) block ...... n, breast, prostate, and lung.
@nl
P1433
P1476
Cyclooxygenase-2 (cox-2) block ...... n, breast, prostate, and lung.
@en
P2093
R E Harris
P2888
P356
10.1007/S10787-009-8049-8
P577
2009-04-01T00:00:00Z